Skip to main content

House bill · H.R. 4273 (119th Congress)

Over-the-Counter Monograph Drug User Fee Amendments

U.S. House of Representatives

Latest action Sep 17, 2025

Sponsor: Robert E. Latta (U.S. Representative, OH-5, Republican)

Follow

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Sep 23, 2026. About our data

Summary

Over-the-Counter Monograph Drug User Fee Amendments This bill reauthorizes the Over-the-Counter (OTC) Monograph Drug User Fee Program (OMUFA) through FY2030 and revises certain aspects of the program, including total fees to be collected and fee due dates. Under current law, many OTC drugs are marketed through compliance with an OTC monograph issued by the Food and Drug Administration (FDA), rather than through an approved new drug application. Monographs establish the conditions under which OTC drugs are generally recognized as safe and effective, and include ingredients, dosages, and other requirements. OMUFA permits the FDA to collect fees from OTC drug facilities and entities requesting changes to a monograph. The bill makes certain changes to OMUFA, including by revising the total facility fee revenue amount to be collected for FY2026-FY2030, revising due dates for facility fees, permitting the FDA to implement a one-time adjustment to facility fees if certain conditions exist, and requiring the FDA to publish facility and order request fee amounts at least 60 days before the start of each fiscal year. Finally, the bill adds as a Tier 2 OTC monograph order request a request for the addition or modification of a testing procedure applicable to a monograph drug, provided the testing procedure reflects a voluntary consensus standard with respect to pharmaceutical quality. (Requestors seeking certain kinds of changes to a monograph are awarded a period of market exclusivity if the FDA makes the requested changes; tier 2 requests are not eligible for market exclusivity.)

Summary from the Congressional Research Service. How we handle summaries

Where it stands

Out of committee and scheduled for a vote by the full chamber.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

House Committee on Energy and Commerce · U.S. House of Representatives

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Cosponsors

Showing the cosponsors who are on Agora, A to Z. The official record may list more.

Read on Congress.gov (opens in a new tab)
  • Democratic1
  • Republican1

This bill has cosponsors from more than one party.

Shown in neutral colors by design; Agora is non-partisan.

As identified by Congress.gov.

Full history

  1. Sep 17, 2025

    Introduced

    Placed on the Union Calendar, Calendar No. 254.

    U.S. House

  2. Sep 17, 2025

    Placed on the Union Calendar, Calendar No. 254.

  3. Sep 17, 2025

    Placed on the Union Calendar, Calendar No. 254.

  4. Sep 17, 2025

    Reported out of committee

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-300.

  5. Sep 17, 2025

    Reported out of committee

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-300.

Show full history (7 earlier events)
  1. Jul 23, 2025

    Committee vote

    Committee Consideration and Mark-up Session Held

  2. Jul 23, 2025

    Committee vote

    Committee Consideration and Mark-up Session Held

  3. Jul 23, 2025

    Reported out of committee

    Ordered to be Reported (Amended) by the Yeas and Nays: 51 - 0.

  4. Jul 23, 2025

    Reported out of committee

    Ordered to be Reported (Amended) by the Yeas and Nays: 51 - 0.

  5. Jul 2, 2025

    Introduced

    Introduced in House

    U.S. House of Representatives

  6. Jul 2, 2025

    Introduced

    Introduced in U.S. House

    U.S. House

  7. Jul 2, 2025

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    U.S. House of Representatives

Read the record